Nabors Energy Transition Corp. II 10-Q13 Nov 232023 Q3 Quarterly reportFinancial data

Company Profile

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
Document and Entity Information - shares	Sep. 30, 2023	Nov. 13, 2023
Document and entity information
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2023
Document Transition Report	false
Entity File Number	001-41744
Entity Registrant Name	NABORS ENERGY TRANSITION CORP. II
Entity Incorporation, State or Country Code	E9
Entity Tax Identification Number	98-1729137
Entity Address, Address Line One	515 West Greens Road
Entity Address, Address Line Two	Suite 1200
Entity Address, City or Town	Houston
Entity Address State Or Province	TX
Entity Address, Postal Zip Code	77067
City Area Code	281
Local Phone Number	874-0035
Entity Current Reporting Status	No
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	true
Entity Central Index Key	0001975218
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q3
Amendment Flag	false
Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-half of one warrant
Document and entity information
Title of 12(b) Security	Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-half of one warrant
Trading Symbol	NETDU
Security Exchange Name	NASDAQ
Class A ordinary shares
Document and entity information
Title of 12(b) Security	Class A ordinary shares, par value $0.0001 per share
Trading Symbol	NETD
Security Exchange Name	NASDAQ
Entity Common Stock, Shares Outstanding		30,500,000
Warrants, exercisable for one Class A ordinary share at an exercise price of $11.50 per share
Document and entity information
Title of 12(b) Security	Warrants, exercisable for one Class A ordinary share at an exercise price of $11.50 per share
Trading Symbol	NETDW
Security Exchange Name	NASDAQ
Class B ordinary shares
Document and entity information
Entity Common Stock, Shares Outstanding		0
Class F ordinary shares
Document and entity information
Entity Common Stock, Shares Outstanding		7,625,000

CONDENSED BALANCE SHEET (UNAUDI

CONDENSED BALANCE SHEET (UNAUDITED)	Sep. 30, 2023 USD ($)
Current assets
Cash	$ 2,020,197
Prepaid expenses	37,498
Short-term prepaid insurance	239,649
Total current assets	2,297,344
Long-term prepaid insurance	190,388
Cash and marketable securities held in Trust Account	311,408,512
Total Assets	313,896,244
Current liabilities
Accounts payable and accrued expenses	80,718
Accrued offering costs	75,000
Total current liabilities	155,718
Overfunding convertible notes - related parties	$ 3,050,000
Overfunding convertible notes - related parties	Related Party [Member]
Deferred legal fees	$ 319,237
Deferred underwriting fee payable	10,675,000
Total Liabilities	14,199,955
Class A ordinary shares subject to possible redemption, 30,500,000 shares at redemption value of $10.21 per share	311,408,512
Shareholders' Deficit
Accumulated deficit	(11,712,986)
Total Shareholders' Deficit	(11,712,223)
Total Liabilities and Shareholders' Deficit	313,896,244
Class F ordinary shares
Shareholders' Deficit
Ordinary shares	$ 763	[1]

[1] On June 16, 2023, the Company issued an additional 2,875,000 Class F ordinary shares to the Sponsor in connection with a share capitalization, resulting in the Sponsor holding an aggregate of 8,625,000 Class F ordinary shares. All share and per share presentations have been retroactively restated. On July 18, 2023, the underwriters purchased 500,000 Units subject to the over-allotment option. On August 27, 2023, the remainder of the over-allotment option to purchase 4,000,000 Units expired and 1,000,000 Class F ordinary shares were forfeited, resulting in the Sponsor and the Company’s independent directors holding an aggregate of 7,625,000 Class F ordinary shares (Note 5).

CONDENSED BALANCE SHEET (UNAU_2

CONDENSED BALANCE SHEET (UNAUDITED)(Parenthetical)	Sep. 30, 2023 $ / shares shares
Preference shares, par value \| $ / shares	$ 0.0001
Preference shares, shares authorized	5,000,000
Preference shares, shares issued	0
Preference shares, shares outstanding	0
Class A ordinary shares
Ordinary shares, par value \| $ / shares	$ 0.0001
Ordinary shares, shares authorized	500,000,000
Ordinary shares, shares issued	0
Ordinary shares, shares outstanding.	0
Ordinary shares subject to possible redemption, shares	30,500,000
Class B ordinary shares
Ordinary shares, par value \| $ / shares	$ 0.0001
Ordinary shares, shares authorized	50,000,000
Ordinary shares, shares issued	0
Ordinary shares, shares outstanding.	0
Class F ordinary shares
Ordinary shares, par value \| $ / shares	$ 0.0001
Ordinary shares, shares authorized	50,000,000
Ordinary shares, shares issued	7,625,000
Ordinary shares, shares outstanding.	7,625,000
Class A ordinary shares subject to possible redemption
Ordinary shares subject to possible redemption, shares	30,500,000
Ordinary shares subject to possible redemption, redemption value (in dollars per share) \| $ / shares	$ 10.21

CONDENSED STATEMENT OF OPERATIO

CONDENSED STATEMENT OF OPERATIONS (UNAUDITED) - USD ($)		3 Months Ended	6 Months Ended
CONDENSED STATEMENT OF OPERATIONS (UNAUDITED) - USD ($)		Sep. 30, 2023	Sep. 30, 2023
General and administrative expenses		$ 253,944	$ 261,371
Loss from operations		(253,944)	(261,371)
Other income:
Change in fair value of over-allotment option liability		402,224	402,224
Other income		290	290
Interest earned on marketable securities held in Trust Account		3,272,323	3,272,323
Unrealized gain on marketable securities held in Trust Account		86,189	86,189
Total other income		3,761,026	3,761,026
Net income		$ 3,507,082	$ 3,499,655
Class A ordinary shares
Other income:
Basic weighted average shares outstanding (in shares)		24,802,198	13,198,830
Diluted weighted average shares outstanding (in shares)		24,802,198	13,198,830
Basic net income per share, Class ordinary shares (in dollar per share)		$ 0.11	$ 0.17
Diluted net income per share, Class ordinary shares (in dollar per share)		$ 0.11	$ 0.17
Class F ordinary shares
Other income:
Basic weighted average shares outstanding (in shares)	[1]	7,546,703	6,998,538
Diluted weighted average shares outstanding (in shares)	[1]	7,625,000	7,040,205
Basic net income per share, Class ordinary shares (in dollar per share)		$ 0.11	$ 0.17
Diluted net income per share, Class ordinary shares (in dollar per share)		$ 0.11	$ 0.17

[1] On June 16, 2023, the Company issued an additional 2,875,000 Class F ordinary shares to the Sponsor in connection with a share capitalization, resulting in the Sponsor holding an aggregate of 8,625,000 Class F ordinary shares. All share and per share presentations have been retroactively restated. On July 18, 2023, the underwriters purchased 500,000 Units subject to the over-allotment option. On August 27, 2023, the remainder of the over-allotment option to purchase 4,000,000 Units expired and 1,000,000 Class F ordinary shares were forfeited, resulting in the Sponsor and the Company’s independent directors holding an aggregate of 7,625,000 Class F ordinary shares (Note 5).

CONDENSED STATEMENT OF OPERAT_2

CONDENSED STATEMENT OF OPERATIONS (UNAUDITED) (Parenthetical) - shares	Aug. 27, 2023	Jul. 18, 2023	Jul. 13, 2023	Jun. 16, 2023	Apr. 24, 2023	Apr. 13, 2023
Over-allotment option
Number of shares subject to forfeiture		500,000
Option to purchase number of units expired	4,000,000
Class F ordinary shares
Number of shares subject to forfeiture			100,000
Issuance of Class F ordinary shares to Sponsor (in shares)			50,000
Number of Shares Held	7,625,000
Class F ordinary shares \| Sponsor and the independent directors
Number of shares subject to forfeiture	1,000,000
Number of Shares Held	7,625,000
Class F ordinary shares \| Sponsor
Issuance of Class F ordinary shares to Sponsor (in shares)			100,000
Number of Shares Held			8,525,000	8,625,000
Class F ordinary shares \| Sponsor \| Founder Shares
Issuance of Class F ordinary shares to Sponsor (in shares)				2,875,000	5,750,000	5,750,000
Number of Shares Held				8,625,000

CONDENSED STATEMENT OF CHANGES

CONDENSED STATEMENT OF CHANGES IN SHAREHOLDER'S DEFICIT (UNAUDITED) - USD ($)		Ordinary Shares Class A ordinary shares	Ordinary Shares Class B ordinary shares	Ordinary Shares Class F ordinary shares	Additional Paid-In Capital Private Placement Warrants	Additional Paid-In Capital Public Warrants	Additional Paid-In Capital	Accumulated Deficit	Class A ordinary shares	Class B ordinary shares	Class F ordinary shares	Private Placement Warrants	Public Warrants	Total
Balance - April 12, 2023 at Apr. 11, 2023		$ 0	$ 0	$ 0			$ 0	$ 0						$ 0
Balance - April 12, 2023 (in shares) at Apr. 11, 2023		0	0	0
Issuance of Class F ordinary shares to Sponsor				$ 863			24,137							25,000
Issuance of Class F ordinary shares to Sponsor (in shares)				8,625,000
Net Income (Loss)								(7,427)						(7,427)
Balance - June 30, 2023 at Jun. 30, 2023				$ 863			24,137	(7,427)						17,573
Balance - June 30, 2023 (in shares) at Jun. 30, 2023				8,625,000
Balance - April 12, 2023 at Apr. 11, 2023		$ 0	$ 0	$ 0			0	0						0
Balance - April 12, 2023 (in shares) at Apr. 11, 2023		0	0	0
Net Income (Loss)														3,499,655
Balance - June 30, 2023 at Sep. 30, 2023				$ 763				(11,712,986)						(11,712,223)
Balance - June 30, 2023 (in shares) at Sep. 30, 2023				7,625,000					0	0	7,625,000
Balance - April 12, 2023 at Jun. 30, 2023				$ 863			24,137	(7,427)						17,573
Balance - April 12, 2023 (in shares) at Jun. 30, 2023				8,625,000
Sale of warrants					$ 9,540,000	$ 3,507,500						$ 9,540,000	$ 3,507,500
Allocated value of transaction costs to warrants							(265,968)							(265,968)
Forfeiture of founder shares(1)	[1]			$ (100)			100
Forfeiture of founder shares (in shares)	[1]			(1,000,000)
Remeasurement of Class A ordinary shares subject to possible redemption							$ (12,805,769)	(15,212,641)						(28,018,410)
Net Income (Loss)								3,507,082						3,507,082
Balance - June 30, 2023 at Sep. 30, 2023				$ 763				$ (11,712,986)						$ (11,712,223)
Balance - June 30, 2023 (in shares) at Sep. 30, 2023				7,625,000					0	0	7,625,000

[1] On June 16, 2023, the Company issued an additional 2,875,000 Class F ordinary shares to the Sponsor in connection with a share capitalization, resulting in the Sponsor holding an aggregate of 8,625,000 Class F ordinary shares. All share and per share presentations have been retroactively restated. On July 18, 2023, the underwriters purchased 500,000 Units subject to the over-allotment option. On August 27, 2023, the remainder of the over-allotment option to purchase 4,000,000 Units expired and 1,000,000 Class F ordinary shares were forfeited, resulting in the Sponsor and the Company’s independent directors holding an aggregate of 7,625,000 Class F ordinary shares (Note 5).

CONDENSED STATEMENT OF CHANGE_2

CONDENSED STATEMENT OF CHANGES IN SHAREHOLDER'S DEFICIT (UNAUDITED) (Parenthetical)	3 Months Ended
	Jun. 30, 2023 shares
Sale of Private Placement Warrants	9,540,000

CONDENSED STATEMENT OF CASH FLO

CONDENSED STATEMENT OF CASH FLOWS	6 Months Ended
CONDENSED STATEMENT OF CASH FLOWS	Sep. 30, 2023 USD ($)
Cash Flows from Operating Activities:
Net income	$ 3,499,655
Adjustments to reconcile net income to net cash used in operating activities:
Payment of formation costs through issuance of Class F ordinary shares	7,427
Interest earned on marketable securities held in Trust Account	(3,272,323)
Unrealized gain on marketable securities held in Trust Account	(86,189)
Change in fair value of over-allotment option liability	(402,224)
Changes in operating assets and liabilities:
Prepaid expenses and other current assets	(10,698)
Short-term prepaid insurance	(239,649)
Long-term prepaid insurance	(190,388)
Accounts payable and accrued expenses	80,718
Deferred legal fee payable	69,237
Net cash used in operating activities	(544,434)
Cash Flows from Investing Activities:
Investment of cash in Trust Account	308,050,000
Net cash used in investing activities	(308,050,000)
Cash Flows from Financing Activities:
Proceeds from sale of Units, net of underwriting discounts paid	298,900,000
Proceeds from sale of Private Placements Warrants	9,540,000
Repayment of promissory note - related party	(217,553)
Proceeds from convertible promissory note - related party	3,050,000
Payment of offering costs	657,816
Net cash provided by financing activities	310,614,631
Net Change in Cash	2,020,197
Cash - Beginning of period	0
Cash - End of period	2,020,197
Non-Cash investing and financing activities:
Offering costs included in accrued offering costs	75,000
Deferred offering costs paid by Sponsor in exchange for issuance of Class F ordinary shares	23,985
Deferred offering costs paid through promissory note - related party	184,341
Deferred underwriting fee payable	10,675,000
Deferred legal fee payable	$ 250,000

DESCRIPTION OF ORGANIZATION AND

DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS	6 Months Ended
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS	Sep. 30, 2023
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS	NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Nabors Energy Transition Corp. II (the “Company”) was incorporated in the Cayman Islands on April 12, 2023. The Company was incorporated for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities (the “Business Combination”). The Company intends to identify solutions, opportunities, companies or technologies that focus on advancing the energy transition; specifically, ones that facilitate, improve or complement the reduction of carbon or greenhouse gas emissions while satisfying growing energy consumption across markets globally. The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). As of September 30, 2023, the Company had not yet commenced operations. All activity for the period from April 12, 2023 (inception) through September 30, 2023 relates to the Company’s formation, the initial public offering (the “Initial Public Offering”), which is described below, and subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues prior to the completion of the Business Combination, at the earliest, and will generate non-operating income in the form of interest income on permitted investments and cash from the proceeds derived from the Initial Public Offering. The Company has selected December 31 as its fiscal year end. On April 24, 2023, Nabors Energy Transition Sponsor II LLC, a Cayman Islands limited liability company (the “Sponsor”), paid $25,000 to cover certain offering costs of the Company in consideration for 5,750,000 Class F ordinary shares, par value $0.0001 per share (the “Founder Shares”). On June 16, 2023, the Company issued 2,875,000 additional Founder Shares to the Sponsor in connection with a share capitalization, resulting in the Sponsor holding an aggregate of 8,625,000 Founder Shares, for approximately $0.003 per share. The registration statement for the Company’s Initial Public Offering was declared effective on July 13, 2023. On July 18, 2023, the Company consummated the Initial Public Offering of 30,500,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units being offered, the “Public Shares”), which includes a partial exercise by the underwriters of their over-allotment option in the amount of 500,000 Units, at $10.00 per unit, generating gross proceeds of $305,000,000 which is discussed in Note 3. Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 9,540,000 warrants (“Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant, in a private placement to the direct or indirect owners of the Sponsor (the “Private Warrantholders”), generating gross proceeds of $9,540,000, which is discussed in Note 4. In addition, the direct or indirect owners of the Sponsor loaned the Company a total of $3,050,000, and in exchange, the Company issued unsecured promissory notes to each lender for an aggregate principal amount of $3,050,000 (see Note 5), as of the closing date of the Initial Public Offering at no interest, which are referred to as the Overfunding Loans. The Overfunding Loans will be repaid upon the closing of the initial Business Combination or converted into warrants of the post-business combination entity at a price of $1.00 per warrant (or any combination thereof), at the Sponsor’s discretion, which warrants will be identical to the Private Placement Warrants. The Overfunding Loans were extended in order to ensure that the amount in the Trust Account (as defined below) was $10.10 per Public Share at the closing of the Initial Public Offering. If the Company does not complete an initial Business Combination, the Company will not repay the Overfunding Loans from amounts held in the Trust Account, and the Trust Account proceeds will be distributed to the Public Shareholders (as defined below), subject to the limitations; however, the Company may repay the Overfunding Loans if there are funds available outside the Trust Account to do so. Transaction costs amounted to $17,966,142 consisting of $6,100,000 of a cash underwriting discount, $10,675,000 of deferred underwriting fees and $1,191,142 of other final offering costs. The Company’s management has broad discretion with respect to the specific application of the net proceeds of its Initial Public Offering, the sale of Private Placement Warrants and the Overfunding Loans, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The Company’s initial Business Combination must be with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held in the Trust Account (net of amounts disbursed to management for working capital purposes and excluding the amount of any deferred underwriting discount held in trust) at the time the Company signs a definitive agreement in connection with the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise is not required to register as an investment company under the Investment Company Act 1940, as amended (the “Investment Company Act”). Following the closing of the Initial Public Offering on July 18, 2023, an amount of $308,050,000 ($10.10 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering, the sale of the Private Placement Warrants and the Overfunding Loans was placed in the trust account (“Trust Account”) with Continental Stock Transfer & Trust Company acting as trustee and held in cash or invested in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below. The Company will provide holders of the Company’s outstanding Public Shares sold in the Initial Public Offering (the “Public Shareholders”) with the opportunity to redeem all or a portion of their Public Shares (including any securities for which such shares are exchanged in any prior migration or other restructuring) upon the completion of a Business Combination either (i) in connection with a general meeting called to approve the Business Combination or (ii) without a shareholder vote by means of a tender offer. Except as required by applicable law or stock exchange listing requirements, the decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then held in the Trust Account (initially $10.10 per Public Share). The per-share amount to be distributed to Public Shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 6). These Public Shares were recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering in accordance with the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” In such case, the Company will proceed with a Business Combination if a majority of the shares voted are voted in favor of the Business Combination. If a shareholder vote is not required by law and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association, conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, shareholder approval of the transaction is required by law, or the Company decides to obtain shareholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. If the Company seeks shareholder approval in connection with a Business Combination, the Initial Shareholders (as defined below) have agreed to vote their Founder Shares and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination. In addition, the Founder Shares are not entitled to redemption rights in connection with the completion of a Business Combination. Notwithstanding the foregoing, the Amended and Restated Memorandum and Articles of Association will provide that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Public Shares, without the prior consent of the Company. The Sponsor and the Company’s officers and directors (the “Initial Shareholders”) have agreed not to propose an amendment to the Amended and Restated Memorandum and Articles of Association (A) in a manner that would affect the substance or timing of the Company’s obligation to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the time frame described below or (B) with respect to any other material provision relating to the rights of holders of Public Shares or pre-initial Business Combination activity, unless the Company provides the Public Shareholders with the opportunity to redeem their Public Shares upon approval of any such amendment. The Company has 24 months (or until July 18, 2025), or such earlier liquidation date as the Company’s board of directors may approve, to consummate an initial Business Combination. If the Company is unable to complete a Business Combination within 24 months, or such earlier liquidation date as the Company’s board of directors may approve, from the closing of the Initial Public Offering (the “Combination Period”), the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten The Sponsor, officers and directors will not be entitled to liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Initial Shareholders should acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to the deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.10. In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party (except for the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or by a prospective target business with which the Company has entered into a letter of intent, confidentiality or other similar agreement or business combination agreement, reduce the amount of funds in the Trust Account to below (i) $10.10 per public share or (ii) such lesser amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, in each case net of the interest which may be withdrawn to pay Company taxes. This liability will not apply with respect to any claims by a third party or Target that executed an agreement waiving any and all rights to seek access to the Trust Account (whether or not such agreement is enforceable) or to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act. Liquidity As of September 30, 2023, the Company had $2,020,197 on the operating bank account and a working capital of $2,141,626. Until the consummation a Business Combination, the Company will be using the funds not held in the Trust Account for identifying and evaluating prospective Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to acquire, and structuring, negotiating and consummating the Business Combination. In connection with the Company’s assessment of going concern considerations in accordance with the authoritative guidance in Financial Accounting Standard Board (“FASB”) Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that the Company currently maintains sufficient liquidity it needs to sustain operations for a reasonable period of time, which is considered to be at least one year from the date that the condensed financial statements are issued.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	6 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	Sep. 30, 2023
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s prospectus for its Initial Public Offering as filed with the SEC on July 17, 2023, as well as the Company’s Current Report on Form 8-K, as filed with the SEC on July 25, 2023. The interim results for the three months ended and for the period from April 12, 2023 (inception) through September 30, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for any future periods. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the JOBS Act, and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of the condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company has $2,020,197 in cash and no cash equivalents as of September 30, 2023. Cash and Marketable Securities in Trust Account At September 30, 2023, substantially all of the assets held in the Trust Account were held in U.S. Treasury Bills. The Company accounts for its marketable securities as trading securities under ASC 320, where securities are presented at fair value on the condensed balance sheet and with unrealized gains or losses, if any, presented on the statements of operations. From April 12, 2023 (inception) through September 30, 2023, the Company did not withdraw any interest earned on the Trust Account. Offering Costs Offering costs consisted of legal, accounting, and other costs incurred through the condensed balance sheet date that were directly related to the Initial Public Offering. Upon completion of the Initial Public Offering, offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs allocated to the warrants were charged to equity. Offering costs allocated to the Class A ordinary shares were charged against the carrying value of Class A ordinary shares subject to possible redemption upon the completion of the Initial Public Offering. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution, which at times may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. The Company has not experienced losses on this account. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition. Income Taxes The Company accounts for income taxes under ASC Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of September 30, 2023, there were no unrecognized tax benefits and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the period presented. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the condensed balance sheet, primarily due to its short-term nature. Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the condensed statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the condensed balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the condensed balance sheet date. The underwriters’ over-allotment option is deemed to be a freestanding financial instrument indexed on the contingently redeemable shares and will be accounted for as a liability pursuant to ASC 480. On August 27, 2023, the remainder of the over-allotment option to purchase 4,000,000 Units expired and the over-allotment option liability was derecognized in the condensed statement of operations. Class A Ordinary Shares Subject to Possible Redemption The Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation, or if there is a shareholder vote or tender offer in connection with the Company’s initial business combination. In accordance with ASC 480-10-S99, the Company classifies Public Shares subject to redemption outside of permanent equity as the redemption provisions are not solely within the control of the Company. The Public Shares sold as part of the Units in the Initial Public Offering were issued with other freestanding instruments (i.e., Public Warrants) and as such, the initial carrying value of Public Shares classified as temporary equity are the allocated proceeds determined in accordance with ASC 470-20. The Company recognizes changes in redemption value immediately as it occurs and will adjust the carrying value of redeemable shares to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable shares will result in charges against additional paid-in capital and accumulated deficit. Accordingly, at September 30, 2023, Class A ordinary shares subject to possible redemption is presented at redemption value as temporary equity, outside of the shareholders’ deficit section of the Company’s condensed balance sheet. At September 30, 2023, the Class A ordinary shares subject to possible redemption reflected on the condensed balance sheet are reconciled in the following table: Gross proceeds from Public Shareholders $ 305,000,000 Less: Proceeds allocated to Public Warrants (3,507,500) Proceeds allocated to the over-allotment option (402,224) Class A ordinary shares issuance costs (17,700,174) Plus: Remeasurement of carrying value to redemption value 28,018,410 Class A ordinary shares subject to possible redemption, September 30, 2023 $ 311,408,512 Net Income per Ordinary Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income per ordinary share is computed by dividing net income by the weighted average number of ordinary shares outstanding for the period. The Company has three classes of ordinary shares, which are referred to as Class A ordinary shares, Class B ordinary shares, and Class F ordinary shares. Income and losses are shared pro rata between the three classes of shares. This presentation contemplates a Business Combination as the most likely outcome, in which case, the three classes of ordinary shares share pro rata in the income of the Company. Accretion associated with the redeemable Class A ordinary shares is excluded from net income per ordinary share as the redemption value approximates fair value. Accretion associated with the redeemable Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value. The calculation of diluted income per share does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering and (ii) the private placement, and any warrants issued in connection with the related party convertible promissory note, since the exercise of the warrants and the conversion of the related party convertible promissory note is contingent upon the occurrence of future events. The warrants are exercisable to purchase 24,790,000 Class A ordinary shares in the aggregate 30 days after the completion of a Business Combination. The related party convertible promissory note is convertible into 3,050,000 warrants upon the closing of a Business Combination. As of September 30, 2023, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted net income per ordinary share is the same as basic net income per ordinary share for the periods presented. The following table reflects the calculation of basic and diluted net income per ordinary share (in dollars, except per share amounts): For the Period from April 12, 2023 For the Three Months Ended (Inception) Through September 30, 2023 September 30, 2023 Class A Class B Class F Class A Class B Class F Basic net income per ordinary share Numerator: Allocation of net income $ 2,688,912 $ — $ 818,170 $ 2,286,999 $ — $ 1,212,656 Denominator: Basic weighted average shares outstanding 24,802,198 — 7,546,703 13,198,830 — 6,998,538 Basic net income per ordinary share $ 0.11 $ — $ 0.11 $ 0.17 $ — $ 0.17 Diluted net income per ordinary share Numerator: Allocation of net income $ 2,682,419 $ — $ 824,663 $ 2,282,290 $ — $ 1,217,365 Denominator: Diluted weighted average shares outstanding 24,802,198 — 7,625,000 13,198,830 — 7,040,205 Diluted net income per ordinary share $ 0.11 $ — $ 0.11 $ 0.17 $ — $ 0.17 Warrant Instruments The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) ASC 480, “Distinguishing Liabilities from Equity” (“ASC 480”) and ASC 815, “Derivatives and Hedging” (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares and whether the warrantholders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each condensed balance sheet date thereafter. Accordingly, the Company evaluated and classified the warrant instruments under equity treatment at its assigned fair value. Share-Based Compensation The Company adopted ASC Topic 718, “Compensation—Stock Compensation”, guidance to account for its share-based compensation. It defines a fair value-based method of accounting for an employee share option or similar equity instrument. The Company recognizes all forms of share-based payments, including share option grants, warrants and restricted stock grants, at their fair value on the grant date, which are based on the estimated number of awards that are ultimately expected to vest. Share-based payments, excluding restricted shares, are valued using a Black-Scholes option pricing model. Grants of share-based payment awards issued to non-employees for services rendered have been recorded at the fair value of the share-based payment, which is the more readily determinable value. The grants are amortized on a straight-line basis over the requisite service periods, which is generally the vesting period. If an award is granted, but vesting does not occur, any previously recognized compensation cost is reversed in the period related to the termination of service. Share-based compensation expense is included in costs and operating expenses depending on the nature of the services provided in the condensed statement of operations. Recent Accounting Standards In August 2020, the FASB issued ASU 2020-06, “Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging— Contracts in Entity’s Own Equity (Subtopic 815-40)” (“ASU 2020-06”), to simplify certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective for fiscal years beginning after December 15, 2023 and should be applied on a full or modified retrospective basis. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company adopted ASU 2020-06 as of April 12, 2023 (inception). There was no effect to the Company’s presented condensed financial statements. Management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s condensed financial statements.

INITIAL PUBLIC OFFERING

INITIAL PUBLIC OFFERING	6 Months Ended
INITIAL PUBLIC OFFERING	Sep. 30, 2023
INITIAL PUBLIC OFFERING
INITIAL PUBLIC OFFERING	NOTE 3. INITIAL PUBLIC OFFERING Pursuant to the Initial Public Offering on July 18, 2023, the Company sold 30,500,000 Units, which includes a partial exercise by the underwriters of their over-allotment option in the amount of 500,000 Units, at a purchase price of $10.00 per Unit generating gross proceeds of $305,000,000. Each Unit consists of one Class A ordinary share and one-half

PRIVATE PLACEMENT

PRIVATE PLACEMENT	6 Months Ended
PRIVATE PLACEMENT	Sep. 30, 2023
PRIVATE PLACEMENT
PRIVATE PLACEMENT	NOTE 4. PRIVATE PLACEMENT Simultaneously with the closing of the Initial Public Offering, the Private Warrantholders purchased an aggregate of 9,540,000 Private Placement Warrants, at a price of $1.00 per Private Placement Warrant, or $9,540,000 in the aggregate, in a private placement. Each whole Private Placement Warrant is exercisable to purchase one whole Class A ordinary share at a price of $11.50 per share. A portion of the proceeds from the sale of the Private Placement Warrants to the Private Warrantholders were added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. The Private Warrantholders and the Company’s officers and directors will agree, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the initial Business Combination.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	6 Months Ended
RELATED PARTY TRANSACTIONS	Sep. 30, 2023
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS	NOTE 5. RELATED PARTY TRANSACTIONS Founder Shares On April 13, 2023, the Sponsor paid an aggregate of $25,000 to cover certain offering costs of the Company in exchange for issuance of 5,750,000 Class F ordinary shares, which were issued on April 24, 2023. On June 16, 2023, the Company issued 2,875,000 additional Founder Shares to the Sponsor in connection with a share capitalization, resulting in the Sponsor holding an aggregate of 8,625,000 Founder Shares, for approximately $0.003 per share. On August 27, 2023, the remainder of the over-allotment option to purchase 4,000,000 Units expired and 1,000,000 Class F ordinary shares were forfeited, resulting in the Sponsor and the Company’s independent directors holding an aggregate of 7,625,000 Class F ordinary shares. The Initial Shareholders have agreed not to transfer, assign or sell any of the Founder Shares until one year after the date of the consummation of the initial Business Combination or earlier if, subsequent to the initial Business Combination, (i) the reported last sale price of the Company’s Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share subdivisions, share dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the initial Business Combination or (ii) the date on which the Company consummates a liquidation, merger, share exchange, or other similar transaction which results in all of the Company’s public shareholders having the right to exchange their ordinary shares of for cash, securities or other property. On July 13, 2023, the Company, the Sponsor and the Company’s two independent directors entered into securities agreements in which the Sponsor forfeited 100,000 Class F ordinary shares and in turn the Company issued the same number of Class F ordinary shares to the Company’s two independent directors ( 50,000 Class F ordinary shares to each director). The 100,000 Class F ordinary shares are subject to forfeiture if the independent directors are removed or resigns from the Company’s board of directors before the Company’s initial Business Combination. The forfeiture of the Founder Shares by the Sponsor, and subsequent issuance of the Founder Shares by the Company to the Company’s independent directors, is in the scope of FASB ASC Topic 718, “Compensation-Stock Compensation” (“ASC 718”). Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the grant date. The Company has estimated that the fair value of the Founder Shares granted to the Company’s independent directors on July 13, 2023 was approximately $59,000 . The Founder Shares were granted subject to a performance condition (i.e. the occurrence of an initial Business Combination). Compensation expense related to the Class F ordinary shares is recognized only when the performance condition is met under the applicable accounting literature in this circumstance. As of September 30, 2023, the Company determined the performance conditions had not been met, and, therefore, no stock-based compensation expense has been recognized. Stock-based compensation would be recognized at the date the performance conditions are met (i.e., upon consummation of an initial business combination) in an amount equal to the number of the Class F ordinary shares vested times the grant date fair value per share (unless subsequently modified) less the amount initially received for the purchase of the Class F ordinary shares. A total of $290 was received on July 13, 2023. Related Party Loans On April 24, 2023, an affiliate of the Sponsor agreed to loan the Company up to $300,000 pursuant to a promissory note (the “Note”). The Note is non-interest bearing, unsecured and due on the earlier of (i) October 21, 2023 and (ii) the consummation of the Initial Public Offering. The Company repaid the Note from the proceeds of the Initial Public Offering not being placed in the Trust Account. The Company borrowed $217,553 under the Note and the Note was repaid on September 11, 2023. Borrowings under the Note are no longer available. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined, and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.00 per warrant. The warrants would be identical to the Private Placement Warrants. As of September 30, 2023, the Company had no borrowings under the Working Capital Loans. Overfunding Convertible Notes – Related Party On July 18, 2023, concurrently with the closing of the Initial Public Offering, direct or indirect owners of the Sponsor loaned the Company a total of $3,050,000,and in exchange, the Company issued unsecured promissory notes to each lender for an aggregate principal amount of $3,050,000 as of the closing of the Initial Public Offering at no interest (the “Overfunding Loans”). The Overfunding Loans will be repaid upon the closing of the initial Business Combination or converted into warrants of the post-business combination entity at a price of $1.00 per warrant (or any combination thereof), at the Sponsor’s discretion, which warrants will be identical to the Private Placement Warrants. The Overfunding Loans were extended in order to ensure that the amount in the Trust Account is $10.10 per public share at the closing of the Initial Public Offering. If the Company does not complete an initial Business Combination, the Company will not repay the Overfunding Loans from amounts held in the Trust Account, and the Trust Account proceeds will be distributed to the Public Shareholders, subject to the limitations described herein; however, the Company may repay the Overfunding Loans if there are funds available outside the Trust Account to do so. The conversion feature was analyzed under ASC470-20, “Debt with Conversion or Other Options,” and the notes did not include any premium or discounts. The conversion option did not include elements that would require bifurcation under ASC815-40, “Derivatives and Hedging.” At September 30, 2023, there is $3,050,000 outstanding under the Overfunding Loans. Administrative Support Agreement The Company entered into an agreement which provides that, commencing on July 14, 2023 through the earlier of consummation of the initial Business Combination and the Company’s liquidation, the Company will reimburse the Sponsor or an affiliate thereof $15,000 per month for office space, utilities, secretarial and administrative support. For the three months ended September 30, 2023, and for the period from April 12, 2023 (inception) through September 30, 2023, the Company incurred $37,500 in fees for these services, of which such amount is included in accrued expenses in the accompanying condensed balance sheet. In addition, the Sponsor, officers and directors, or any of their respective affiliates will be reimbursed for any out-of-pocket expenses incurred in connection with activities on the Company’s behalf such as identifying potential target businesses and performing due diligence on suitable Business Combinations. Any such payments prior to an initial Business Combination will be made using funds held outside the Trust Account.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	6 Months Ended
COMMITMENTS AND CONTINGENCIES	Sep. 30, 2023
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES	NOTE 6. COMMITMENTS AND CONTINGENCIES Registration and Shareholder Rights The holders of Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans and the Overfunding Loans (and the Class A ordinary shares issuable upon exercise or conversion thereof) are entitled to registration rights pursuant to a registration rights agreement entered into on July 13, 2023. These holders are entitled to make up to three demands, that the Company register such securities for sale under the Securities Act. In addition, these holders have “piggy-back” registration rights with respect to certain underwritten offerings the Company may conduct. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The Company granted the underwriters a 45-day option from the date of the prospectus for the Initial Public Offering to purchase up to 4,500,000 additional Units to cover over-allotments, if any. On July 18, 2023, the underwriters partially exercised its over-allotment option and purchased an additional 500,000 Units. The underwriters had 45 days from the date of the prospectus for the Initial Public Offering to purchase the remaining 4,000,000 Units. On August 27, 2023, the remainder of the over-allotment option to purchase 4,000,000 Units expired. The underwriters were entitled to an underwriting discount of $0.20 per unit, or $6,100,000 in the aggregate, paid upon the closing of the Initial Public Offering. In addition, $0.35 per unit, or $10,675,000 in the aggregate, will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes an initial Business Combination, subject to the terms of the underwriting agreement for the Initial Public Offering. Deferred Legal Fees As of September 30, 2023, the Company had a total of $319,237 of deferred legal fees to be paid to the Company’s legal advisors upon consummation of the Business Combination, which is included in the accompanying condensed balance sheet as of September 30, 2023. Risks and Uncertainties In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further the impact of this actions and related sanctions on the world economy is not determinable as of the date of these condensed financial statements, and the specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these condensed financial statements.

SHAREHOLDER'S EQUITY

SHAREHOLDER'S EQUITY	6 Months Ended
SHAREHOLDER'S EQUITY	Sep. 30, 2023
SHAREHOLDER'S EQUITY
SHAREHOLDER'S EQUITY	NOTE 7. SHAREHOLDERS’ EQUITY (DEFICIT) Preference Shares Class A Ordinary Shares Class B Ordinary Shares Class F Ordinary Shares Prior to the completion of the initial Business Combination, holders of the Class F ordinary shares will have the right to elect all of the Company’s directors prior to an initial Business Combination. On any other matter submitted to a vote of the Company’s shareholders, holders of the Class A ordinary shares, holders of the Class B ordinary shares (if any) and holders of the Class F ordinary shares will vote together as a single class, except as required by law or share exchange rule. Each ordinary share will have one vote on all such matters. Following the completion of the initial Business Combination and the automatic conversion of the Class F ordinary shares into Class B ordinary shares, holders of the Class A ordinary shares and Class B ordinary shares will generally vote together as a single class, except as required by law or stock exchange rule, on all matters presented for a shareholder vote with each Class A ordinary share entitling the holder to one vote per share and each Class B ordinary share entitling the holder to ten votes per share. The Class F ordinary shares will automatically convert into Class B ordinary shares at the time of an initial Business Combination, or earlier at the option of the holder, on a one-for-one basis, and, prior to and following the initial Business Combination, each Class B ordinary share will be convertible, at the option of the holder, into one Class A ordinary share, subject to adjustment for share subdivisions, share dividends, reorganizations, recapitalizations and the like and in each case, subject to further adjustment as provided herein. In the case that additional Class A ordinary shares, or equity-linked securities, are issued or deemed issued in excess of the amounts sold in the Initial Public Offering and related to the closing of the initial Business Combination, the ratio at which the Founder Shares shall convert into Class A ordinary shares or Class B ordinary shares, as applicable, will be adjusted (unless the holders of a majority of the outstanding Founder Shares agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of Class A ordinary shares or Class B ordinary shares, as applicable, issuable upon conversion thereof will equal, in the aggregate, on an as-converted basis, 20% of the sum of the total number of all ordinary shares outstanding upon the completion of the Initial Public Offering plus all Class A ordinary shares and equity-linked securities issued or deemed issued in connection with the initial Business Combination (excluding any shares or equity-linked securities issued, or to be issued, to any seller in the initial Business Combination, any private placement warrants issued to our Sponsor or its affiliates upon conversion of Working Capital Loans made to us and the Overfunding Loan). Warrants In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination (net of redemptions), and (z) the volume weighted average price of the Class A ordinary shares during the 10 trading day period ending on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, (i) the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price and (ii) the $18.00 per share redemption trigger price described under “Redemption of warrants for cash when the price per Class A ordinary share equals or exceeds $18.00” will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price. Notwithstanding the above, if the Company’s Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, it will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, it will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. The Private Placement Warrants (including the Class A ordinary shares issuable upon exercise of the Private Placement Warrants) will not be transferable, assignable or salable until 30 days after the completion of an initial Business Combination, subject to certain limited exceptions, and they will not be redeemable by the Company. The Private Placement Warrants may be exercised for cash or on a cashless basis. Except as described herein, the Private Placement Warrants have terms and provisions that are identical to those of the Public Warrants, including as to exercise price, exercisability and exercise period. Redemption of warrants for cash when the price per Class A ordinary share equals or exceeds $18.00 Once the warrants become exercisable, the Company may redeem the outstanding Public Warrants: ● in whole and not in part; ● at a price of $0.01 per warrant; ● upon a minimum of 30 days ’ prior written notice of redemption (the “ 30-day redemption period”); and ● if, and only if, the reported last sale price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for share subdivisions, share dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30 -trading day period commencing at least 150 days after completion of our initial Business Combination and ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrantholders. The Company will not redeem the warrants as described above unless a registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the warrants is effective, and a current prospectus relating to those Class A ordinary shares is available throughout the 30- day redemption period or the company has elected to require exercise of the warrants on a cashless basis. If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws. The Company has established the last of the redemption criterion discussed above to prevent a redemption call unless there is at the time of the call a significant premium to the warrant exercise price. If the foregoing conditions are satisfied and the Company issues a notice of redemption of the warrants, each warrantholder will be entitled to exercise its warrant prior to the scheduled redemption date. However, the price of the Class A ordinary shares may fall below the $18.00 redemption trigger price (as adjusted for share subdivisions, share dividends, reorganizations, recapitalizations and the like) as well as the $11.50 (for whole shares) warrant exercise price after the redemption notice is issued. In no event will the Company be required to net cash settle any warrant. If the Company is unable to complete an initial Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such warrants. Accordingly, the warrants may expire worthless.

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS	9 Months Ended
FAIR VALUE MEASUREMENTS	Sep. 30, 2023
FAIR VALUE MEASUREMENTS
FAIR VALUE MEASUREMENTS	NOTE 8. FAIR VALUE MEASUREMENTS The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1: Level 2: Level 3: At September 30, 2023, assets held in the Trust Account were comprised of $853 in cash and $311,407,659 in U.S. Treasury bills. During the period from April 12, 2023 (inception) through September 30, 2023, the Company did not withdraw any interest income from the Trust Account. The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at September 30, 2023 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: September 30, Level 2023 Assets: Marketable securities held in Trust Account 1 $ 311,407,659 The following table presents information about the Company’s liabilities that are measured at fair value on July 18, 2023 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value. July 18, Level 2023 Liabilities: Over-allotment option 3 $ 402,224 The over-allotment option was initially accounted for as a liability in accordance with ASC 815-40 and was presented within liabilities on the condensed balance sheet. The over-allotment liability is measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of over-allotment liability in the statement of operations. On August 27, 2023, the remainder of the over-allotment option to purchase 4,000,000 Units expired and the over-allotment option liability was derecognized in the condensed statement of operations. The Company used a Black-Scholes model to value the over-allotment option. The over-allotment option liability was classified within Level 3 of the fair value hierarchy at the measurement dates due to the use of unobservable inputs inherent in pricing models are assumptions related to expected share-price volatility, expected life and risk-free interest rate. The Company estimates the volatility of its ordinary share based on historical volatility that matches the expected remaining life of the option. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the option. The expected life of the option is assumed to be equivalent to their remaining contractual term. The key inputs into the Black-Scholes model were as follows at initial measurement of the over-allotment option: Input July 18, 2023 Risk-free interest rate 5.37 % Expected term (years) 0.12 Expected volatility 4.49 % Exercise price $ 10.00 Fair value of over-allotment unit $ 0.101 The following table provides a summary of the changes in the fair value of the Company’s Level 3 financial instruments that are measured at fair value on a recurring basis: Over-allotment liability Fair value at April 12, 2023 (inception) $ — Initial measurement of over-allotment option at July 18, 2023 402,224 Fair value at July 18, 2023 $ 402,224 Derecognition of over-allotment option liability on August 27, 2023 (402,224) Fair value at September 30, 2023 $ — The public warrants were valued using a Monte Carlo simulation in a risk-neutral framework (a special case of the Income Approach). The public warrants have been classified within shareholders’ equity (deficit) and will not require remeasurement after issuance. The following table presents the quantitative information regarding market assumptions used in the valuation of the public warrants: July 18, 2023 Market price of public stock $ 10.12 Term (years) 5.0 Risk-free rate 3.91 % Dividend yield 0.00 % Volatility 40.0 % Probability of merger 8 %

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	6 Months Ended
SUBSEQUENT EVENTS	Sep. 30, 2023
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS	NOTE 9. SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred after the condensed balance sheet date up to the date that the condensed financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the condensed financial statements.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	6 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	Sep. 30, 2023
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s prospectus for its Initial Public Offering as filed with the SEC on July 17, 2023, as well as the Company’s Current Report on Form 8-K, as filed with the SEC on July 25, 2023. The interim results for the three months ended and for the period from April 12, 2023 (inception) through September 30, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for any future periods.
Emerging Growth Company	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the JOBS Act, and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates	Use of Estimates The preparation of the condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company has $2,020,197 in cash and no cash equivalents as of September 30, 2023.
Cash and Marketable Securities in Trust Account	Cash and Marketable Securities in Trust Account At September 30, 2023, substantially all of the assets held in the Trust Account were held in U.S. Treasury Bills. The Company accounts for its marketable securities as trading securities under ASC 320, where securities are presented at fair value on the condensed balance sheet and with unrealized gains or losses, if any, presented on the statements of operations. From April 12, 2023 (inception) through September 30, 2023, the Company did not withdraw any interest earned on the Trust Account.
Offering Costs	Offering Costs Offering costs consisted of legal, accounting, and other costs incurred through the condensed balance sheet date that were directly related to the Initial Public Offering. Upon completion of the Initial Public Offering, offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs allocated to the warrants were charged to equity. Offering costs allocated to the Class A ordinary shares were charged against the carrying value of Class A ordinary shares subject to possible redemption upon the completion of the Initial Public Offering.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution, which at times may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. The Company has not experienced losses on this account. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition.
Income Taxes	Income Taxes The Company accounts for income taxes under ASC Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of September 30, 2023, there were no unrecognized tax benefits and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the period presented.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the condensed balance sheet, primarily due to its short-term nature.
Derivative Financial Instruments	Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the condensed statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the condensed balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the condensed balance sheet date. The underwriters’ over-allotment option is deemed to be a freestanding financial instrument indexed on the contingently redeemable shares and will be accounted for as a liability pursuant to ASC 480. On August 27, 2023, the remainder of the over-allotment option to purchase 4,000,000 Units expired and the over-allotment option liability was derecognized in the condensed statement of operations.
Class A Ordinary Shares Subject to Possible Redemption	Class A Ordinary Shares Subject to Possible Redemption The Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation, or if there is a shareholder vote or tender offer in connection with the Company’s initial business combination. In accordance with ASC 480-10-S99, the Company classifies Public Shares subject to redemption outside of permanent equity as the redemption provisions are not solely within the control of the Company. The Public Shares sold as part of the Units in the Initial Public Offering were issued with other freestanding instruments (i.e., Public Warrants) and as such, the initial carrying value of Public Shares classified as temporary equity are the allocated proceeds determined in accordance with ASC 470-20. The Company recognizes changes in redemption value immediately as it occurs and will adjust the carrying value of redeemable shares to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable shares will result in charges against additional paid-in capital and accumulated deficit. Accordingly, at September 30, 2023, Class A ordinary shares subject to possible redemption is presented at redemption value as temporary equity, outside of the shareholders’ deficit section of the Company’s condensed balance sheet. At September 30, 2023, the Class A ordinary shares subject to possible redemption reflected on the condensed balance sheet are reconciled in the following table: Gross proceeds from Public Shareholders $ 305,000,000 Less: Proceeds allocated to Public Warrants (3,507,500) Proceeds allocated to the over-allotment option (402,224) Class A ordinary shares issuance costs (17,700,174) Plus: Remeasurement of carrying value to redemption value 28,018,410 Class A ordinary shares subject to possible redemption, September 30, 2023 $ 311,408,512
Net Income per Ordinary Share	Net Income per Ordinary Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income per ordinary share is computed by dividing net income by the weighted average number of ordinary shares outstanding for the period. The Company has three classes of ordinary shares, which are referred to as Class A ordinary shares, Class B ordinary shares, and Class F ordinary shares. Income and losses are shared pro rata between the three classes of shares. This presentation contemplates a Business Combination as the most likely outcome, in which case, the three classes of ordinary shares share pro rata in the income of the Company. Accretion associated with the redeemable Class A ordinary shares is excluded from net income per ordinary share as the redemption value approximates fair value. Accretion associated with the redeemable Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value. The calculation of diluted income per share does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering and (ii) the private placement, and any warrants issued in connection with the related party convertible promissory note, since the exercise of the warrants and the conversion of the related party convertible promissory note is contingent upon the occurrence of future events. The warrants are exercisable to purchase 24,790,000 Class A ordinary shares in the aggregate 30 days after the completion of a Business Combination. The related party convertible promissory note is convertible into 3,050,000 warrants upon the closing of a Business Combination. As of September 30, 2023, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted net income per ordinary share is the same as basic net income per ordinary share for the periods presented. The following table reflects the calculation of basic and diluted net income per ordinary share (in dollars, except per share amounts): For the Period from April 12, 2023 For the Three Months Ended (Inception) Through September 30, 2023 September 30, 2023 Class A Class B Class F Class A Class B Class F Basic net income per ordinary share Numerator: Allocation of net income $ 2,688,912 $ — $ 818,170 $ 2,286,999 $ — $ 1,212,656 Denominator: Basic weighted average shares outstanding 24,802,198 — 7,546,703 13,198,830 — 6,998,538 Basic net income per ordinary share $ 0.11 $ — $ 0.11 $ 0.17 $ — $ 0.17 Diluted net income per ordinary share Numerator: Allocation of net income $ 2,682,419 $ — $ 824,663 $ 2,282,290 $ — $ 1,217,365 Denominator: Diluted weighted average shares outstanding 24,802,198 — 7,625,000 13,198,830 — 7,040,205 Diluted net income per ordinary share $ 0.11 $ — $ 0.11 $ 0.17 $ — $ 0.17
Warrant Instruments	Warrant Instruments The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) ASC 480, “Distinguishing Liabilities from Equity” (“ASC 480”) and ASC 815, “Derivatives and Hedging” (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares and whether the warrantholders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each condensed balance sheet date thereafter. Accordingly, the Company evaluated and classified the warrant instruments under equity treatment at its assigned fair value.
Share-Based Compensation	Share-Based Compensation The Company adopted ASC Topic 718, “Compensation—Stock Compensation”, guidance to account for its share-based compensation. It defines a fair value-based method of accounting for an employee share option or similar equity instrument. The Company recognizes all forms of share-based payments, including share option grants, warrants and restricted stock grants, at their fair value on the grant date, which are based on the estimated number of awards that are ultimately expected to vest. Share-based payments, excluding restricted shares, are valued using a Black-Scholes option pricing model. Grants of share-based payment awards issued to non-employees for services rendered have been recorded at the fair value of the share-based payment, which is the more readily determinable value. The grants are amortized on a straight-line basis over the requisite service periods, which is generally the vesting period. If an award is granted, but vesting does not occur, any previously recognized compensation cost is reversed in the period related to the termination of service. Share-based compensation expense is included in costs and operating expenses depending on the nature of the services provided in the condensed statement of operations.
Recent Accounting Pronouncements	Recent Accounting Standards In August 2020, the FASB issued ASU 2020-06, “Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging— Contracts in Entity’s Own Equity (Subtopic 815-40)” (“ASU 2020-06”), to simplify certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective for fiscal years beginning after December 15, 2023 and should be applied on a full or modified retrospective basis. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company adopted ASU 2020-06 as of April 12, 2023 (inception). There was no effect to the Company’s presented condensed financial statements. Management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s condensed financial statements.

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - (Tables)	6 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - (Tables)	Sep. 30, 2023
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Summary of Class A ordinary shares subject to possible redemption	At September 30, 2023, the Class A ordinary shares subject to possible redemption reflected on the condensed balance sheet are reconciled in the following table: Gross proceeds from Public Shareholders $ 305,000,000 Less: Proceeds allocated to Public Warrants (3,507,500) Proceeds allocated to the over-allotment option (402,224) Class A ordinary shares issuance costs (17,700,174) Plus: Remeasurement of carrying value to redemption value 28,018,410 Class A ordinary shares subject to possible redemption, September 30, 2023 $ 311,408,512
Schedule of basic and diluted net income per ordinary share	The following table reflects the calculation of basic and diluted net income per ordinary share (in dollars, except per share amounts): For the Period from April 12, 2023 For the Three Months Ended (Inception) Through September 30, 2023 September 30, 2023 Class A Class B Class F Class A Class B Class F Basic net income per ordinary share Numerator: Allocation of net income $ 2,688,912 $ — $ 818,170 $ 2,286,999 $ — $ 1,212,656 Denominator: Basic weighted average shares outstanding 24,802,198 — 7,546,703 13,198,830 — 6,998,538 Basic net income per ordinary share $ 0.11 $ — $ 0.11 $ 0.17 $ — $ 0.17 Diluted net income per ordinary share Numerator: Allocation of net income $ 2,682,419 $ — $ 824,663 $ 2,282,290 $ — $ 1,217,365 Denominator: Diluted weighted average shares outstanding 24,802,198 — 7,625,000 13,198,830 — 7,040,205 Diluted net income per ordinary share $ 0.11 $ — $ 0.11 $ 0.17 $ — $ 0.17

FAIR VALUE MEASUREMENTS (Tables

FAIR VALUE MEASUREMENTS (Tables)	9 Months Ended
FAIR VALUE MEASUREMENTS (Tables)	Sep. 30, 2023
FAIR VALUE MEASUREMENTS
Schedule of assets that are measured at fair value on a recurring basis	September 30, Level 2023 Assets: Marketable securities held in Trust Account 1 $ 311,407,659
Schedule of liabilities that are measured at fair value	July 18, Level 2023 Liabilities: Over-allotment option 3 $ 402,224
Summary of the changes in the fair value of the Company's Level 3 financial instruments that are measured at fair value on a recurring basis	Over-allotment liability Fair value at April 12, 2023 (inception) $ — Initial measurement of over-allotment option at July 18, 2023 402,224 Fair value at July 18, 2023 $ 402,224 Derecognition of over-allotment option liability on August 27, 2023 (402,224) Fair value at September 30, 2023 $ —
Public Warrants
FAIR VALUE MEASUREMENTS
Schedule of valuation assumptions	July 18, 2023 Market price of public stock $ 10.12 Term (years) 5.0 Risk-free rate 3.91 % Dividend yield 0.00 % Volatility 40.0 % Probability of merger 8 %
Over-allotment option
FAIR VALUE MEASUREMENTS
Schedule of valuation assumptions	Input July 18, 2023 Risk-free interest rate 5.37 % Expected term (years) 0.12 Expected volatility 4.49 % Exercise price $ 10.00 Fair value of over-allotment unit $ 0.101

DESCRIPTION OF ORGANIZATION A_2

DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details) - USD ($)						3 Months Ended	6 Months Ended
	Jul. 18, 2023	Jul. 13, 2023	Jun. 16, 2023	Apr. 24, 2023	Apr. 13, 2023	Jun. 30, 2023	Sep. 30, 2023	Aug. 27, 2023
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Amount paid						$ 25,000
Gross proceeds from sale of units							$ 298,900,000
Amount in Trust Account per public share	$ 10.10
Transaction costs							17,966,142
Cash underwriting discount	$ 6,100,000						6,100,000
Deferred underwriting fees	10,675,000						10,675,000
Other offering costs							$ 1,191,142
Threshold minimum aggregate fair market value as a percentage of the assets held in the Trust Account							80%
Threshold percentage of outstanding voting securities of the target to be acquired by post-transaction company to complete business combination							50%
Amount placed in Trust Account	308,050,000
Threshold percentage of public shares subject to redemption without the company's prior written consent							15%
Obligation to redeem public shares if entity does not complete a business combination (as a percent)							100%
Threshold period to consummate initial Business Combination							24 months
Threshold business days for redemption of public shares							10 days
Maximum net interest to pay dissolution expenses							$ 100,000
Gross proceeds	$ 305,000,000
Purchase price of warrants							$ 11.50
Cash in operating bank account							$ 2,020,197
Working capital deficit							$ 2,141,626
Initial Public Offering
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Issue price per share or unit	$ 10
Number of units sold	30,500,000
Gross proceeds from sale of units	$ 305,000,000
Over-allotment option
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Number of units sold	500,000
Private placement \| Private Placement Warrants
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Number of warrants sold	9,540,000
Sale price per warrant	$ 1
Gross proceeds from sale of warrants	$ 9,540,000
Class F ordinary shares
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Number of shares issued		50,000
Par value per share							$ 0.0001
Number of shares held.								7,625,000
Sponsor \| Class F ordinary shares
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Number of shares issued		100,000
Number of shares held.		8,525,000	8,625,000
Issue price per share or unit			$ 0.003
Founder Shares \| Sponsor \| Class F ordinary shares
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Amount paid				$ 25,000	$ 25,000
Number of shares issued			2,875,000	5,750,000	5,750,000
Par value per share				$ 0.0001
Number of shares held.			8,625,000
Issue price per share or unit			$ 0.003
Overfunding Loans \| Sponsor
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Amount of loan	3,050,000
Aggregate principal amount	$ 3,050,000
Interest rate (in percent)	0%						0%
Conversion price	$ 1						$ 1
Amount in Trust Account per public share	$ 10.10
Overfunding Loans \| Sponsor \| Overfunding Notes
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Amount of loan							$ 3,050,000
Aggregate principal amount							$ 3,050,000
Related Party Loans \| Sponsor \| Notes payable, other payables
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Maximum loan				$ 300,000

SUMMARY OF SIGNIFICANT ACCOUN_4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Cash and Cash Equivalents (Details)	Sep. 30, 2023 USD ($)
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Cash	$ 2,020,197
Cash equivalents	$ 0

SUMMARY OF SIGNIFICANT ACCOUN_5

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Income Taxes (Details)	Sep. 30, 2023 USD ($)
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Amount of unrecognized tax benefits	$ 0
Amount accrued for interest and penalties	$ 0

SUMMARY OF SIGNIFICANT ACCOUN_6

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Derivative Financial Instruments (Details)	Aug. 27, 2023 shares
Over-allotment option
Subsidiary, Sale of Stock [Line Items]
Option to purchase number of units expired	4,000,000

SUMMARY OF SIGNIFICANT ACCOUN_7

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Class A Ordinary Shares Subject to Possible Redemption (Details) - Class A ordinary shares subject to possible redemption	6 Months Ended
	Sep. 30, 2023 USD ($)
Investment Company, Change in Net Assets [Line Items]
Gross proceeds from Public Shareholders	$ 305,000,000
Proceeds allocated to Public Warrants	(3,507,500)
Proceeds allocated to the over-allotment option	(402,224)
Class A ordinary shares issuance costs	(17,700,174)
Remeasurement of carrying value to redemption value	28,018,410
Class A ordinary shares subject to possible redemption, September 30, 2023	$ 311,408,512

SUMMARY OF SIGNIFICANT ACCOUN_8

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Net Income per Ordinary Share (Details) - USD ($)				3 Months Ended	6 Months Ended
		Jul. 18, 2023	Jul. 13, 2023	Sep. 30, 2023	Sep. 30, 2023
Net Income per Ordinary Share
Promissory note convertible into number of warrants					3,050,000
Over-allotment option
Net Income per Ordinary Share
Number of shares subject to forfeiture		500,000
Class A ordinary shares
Net Income per Ordinary Share
Warrants exercisable to purchase number of shares				24,790,000	24,790,000
Threshold period for exercise of warrants after the completion of a Business Combination					30 days
Numerator:
Allocation of net income - Basic				$ 2,688,912	$ 2,286,999
Allocation of net income - Diluted				$ 2,682,419	$ 2,282,290
Denominator:
Basic weighted average shares outstanding (in shares)				24,802,198	13,198,830
Diluted weighted average shares outstanding (in shares)				24,802,198	13,198,830
Basic net income per share, Class ordinary shares (in dollar per share)				$ 0.11	$ 0.17
Diluted net income per share, Class ordinary shares (in dollar per share)				$ 0.11	$ 0.17
Class F ordinary shares
Net Income per Ordinary Share
Number of shares subject to forfeiture			100,000
Numerator:
Allocation of net income - Basic				$ 818,170	$ 1,212,656
Allocation of net income - Diluted				$ 824,663	$ 1,217,365
Denominator:
Basic weighted average shares outstanding (in shares)	[1]			7,546,703	6,998,538
Diluted weighted average shares outstanding (in shares)	[1]			7,625,000	7,040,205
Basic net income per share, Class ordinary shares (in dollar per share)				$ 0.11	$ 0.17
Diluted net income per share, Class ordinary shares (in dollar per share)				$ 0.11	$ 0.17

[1] On June 16, 2023, the Company issued an additional 2,875,000 Class F ordinary shares to the Sponsor in connection with a share capitalization, resulting in the Sponsor holding an aggregate of 8,625,000 Class F ordinary shares. All share and per share presentations have been retroactively restated. On July 18, 2023, the underwriters purchased 500,000 Units subject to the over-allotment option. On August 27, 2023, the remainder of the over-allotment option to purchase 4,000,000 Units expired and 1,000,000 Class F ordinary shares were forfeited, resulting in the Sponsor and the Company’s independent directors holding an aggregate of 7,625,000 Class F ordinary shares (Note 5).

INITIAL PUBLIC OFFERING (Detail

INITIAL PUBLIC OFFERING (Details) - USD ($)	Jul. 18, 2023	Sep. 30, 2023
INITIAL PUBLIC OFFERING
Exercise price of warrant		$ 11.50
Gross proceeds	$ 305,000,000
Initial Public Offering
INITIAL PUBLIC OFFERING
Number of units sold	30,500,000
Issue price per share or unit	$ 10
Initial Public Offering \| Public Warrants
INITIAL PUBLIC OFFERING
Number of warrants in a Unit	0.5
Initial Public Offering \| Class A ordinary shares
INITIAL PUBLIC OFFERING
Number of shares in a Unit	1
Initial Public Offering \| Class A ordinary shares \| Public Warrants
INITIAL PUBLIC OFFERING
Number of shares to purchase per warrant	1
Exercise price of warrant	$ 11.50
Over-allotment option
INITIAL PUBLIC OFFERING
Number of units sold	500,000

PRIVATE PLACEMENT (Details)

PRIVATE PLACEMENT (Details) - USD ($)		6 Months Ended
PRIVATE PLACEMENT (Details) - USD ($)	Jul. 18, 2023	Sep. 30, 2023
PRIVATE PLACEMENT
Exercise price of warrant		$ 11.50
Class A ordinary shares
PRIVATE PLACEMENT
Threshold period for not to transfer, assign or sell any of their shares or warrants after the completion of the initial business combination		30 days
Private placement \| Private Placement Warrants
PRIVATE PLACEMENT
Number of warrants sold	9,540,000
Sale price per warrant	$ 1
Gross proceeds from sale of warrants	$ 9,540,000
Threshold period for not to transfer, assign or sell any of their shares or warrants after the completion of the initial business combination	30 days
Private placement \| Private Placement Warrants \| Class A ordinary shares
PRIVATE PLACEMENT
Number of shares to purchase per warrant	1
Exercise price of warrant	$ 11.50

RELATED PARTY TRANSACTIONS - Fo

RELATED PARTY TRANSACTIONS - Founder Shares (Details)								3 Months Ended	6 Months Ended
RELATED PARTY TRANSACTIONS - Founder Shares (Details)	Aug. 27, 2023 shares	Jul. 18, 2023 shares	Jul. 13, 2023 USD ($) director shares	Jun. 16, 2023 $ / shares shares	Apr. 24, 2023 USD ($) shares	Apr. 13, 2023 USD ($) shares	Apr. 12, 2023	Jun. 30, 2023 USD ($)	Sep. 30, 2023 USD ($) $ / shares
RELATED PARTY TRANSACTIONS
Amount paid \| $								$ 25,000
Class F ordinary shares
RELATED PARTY TRANSACTIONS
Number of shares issued			50,000
Number of shares forfeited	1,000,000
Number of shares held.	7,625,000
Number of shares subject to forfeiture			100,000
Number of independent directors to whom the shares issued \| director			2
Stock-based compensation expense \| $									$ 0
Amount received for purchase of shares \| $			$ 290
Sponsor \| Class F ordinary shares
RELATED PARTY TRANSACTIONS
Number of shares issued			100,000
Issue price per share \| $ / shares				$ 0.003
Number of shares forfeited			100,000
Number of shares held.			8,525,000	8,625,000
Percentage of issued and outstanding shares									20%
Sponsor and the independent directors
RELATED PARTY TRANSACTIONS
Number of units sold		500,000
Sponsor and the independent directors \| Class F ordinary shares
RELATED PARTY TRANSACTIONS
Number of shares held.	7,625,000
Number of shares subject to forfeiture	1,000,000
Over-allotment option
RELATED PARTY TRANSACTIONS
Option to purchase number of units expired	4,000,000
Number of units sold		500,000
Number of shares subject to forfeiture		500,000
Period of over-allotment		45 days					45 days
Founder Shares
RELATED PARTY TRANSACTIONS
Fair value of granted shares \| $			$ 59,000
Founder Shares \| Sponsor \| Class F ordinary shares
RELATED PARTY TRANSACTIONS
Amount paid \| $					$ 25,000	$ 25,000
Number of shares issued				2,875,000	5,750,000	5,750,000
Issue price per share \| $ / shares				$ 0.003
Number of shares held.				8,625,000
Threshold period for not to transfer, assign or sell any of shares after the completion of the Business Combination									1 year
Stock price trigger to transfer, assign or sell any shares after the completion of the Business Combination (in dollars per share) \| $ / shares									$ 12
Threshold trading days for transfer, assign or sale of shares after the completion of the Business Combination									20 days
Threshold consecutive trading days for transfer, assign or sale of shares after the completion of the business combination									30 days
Threshold period after the Business Combination in which the 20 trading days within any 30 trading day period commences									150 days

RELATED PARTY TRANSACTIONS - Re

RELATED PARTY TRANSACTIONS - Related Party Loans (Details) - Related Party Loans - USD ($)	6 Months Ended
	Sep. 30, 2023	Apr. 24, 2023
Note \| Sponsor
RELATED PARTY TRANSACTIONS
Maximum loan		$ 300,000
Amount borrowed	$ 217,553
Working Capital Loans \| Sponsor or an affiliate of the Sponsor, or officers and directors
RELATED PARTY TRANSACTIONS
Maximum amount of loan convertible into warrants		$ 1,500,000
Conversion price per warrant		$ 1
Amount borrowed	$ 0

RELATED PARTY TRANSACTIONS - Sp

RELATED PARTY TRANSACTIONS - Sponsor Loan (Details) - USD ($)	Jul. 18, 2023	Sep. 30, 2023
RELATED PARTY TRANSACTIONS
Amount in Trust Account per public share	$ 10.10
Overfunding Loans \| Sponsor
RELATED PARTY TRANSACTIONS
Amount of loan	$ 3,050,000
Interest rate (in percent)	0%	0%
Aggregate principal amount	$ 3,050,000
Conversion price	$ 1	$ 1
Amount in Trust Account per public share	$ 10.10
Outstanding balance		$ 3,050,000

RELATED PARTY TRANSACTIONS - Ad

RELATED PARTY TRANSACTIONS - Administrative Support Agreement (Details) - Administrative Support Agreement - Sponsor or an affiliate - USD ($)		6 Months Ended
	Jul. 14, 2023	Sep. 30, 2023
RELATED PARTY TRANSACTIONS
Amount per month for office space, utilities, secretarial and administrative support.	$ 15,000
Administrative fees expense		$ 37,500

COMMITMENTS AND CONTINGENCIES -

COMMITMENTS AND CONTINGENCIES - Registration and Shareholder Rights (Details)	6 Months Ended
	Sep. 30, 2023 item
COMMITMENTS AND CONTINGENCIES
Maximum number of demands for registration of securities	3

COMMITMENTS AND CONTINGENCIES_2

COMMITMENTS AND CONTINGENCIES - Underwriters Agreement (Details) - USD ($)			6 Months Ended
	Jul. 18, 2023	Apr. 12, 2023	Sep. 30, 2023	Aug. 27, 2023
COMMITMENTS AND CONTINGENCIES
Underwriting discount per unit	$ 0.20
Underwriting discount	$ 6,100,000		$ 6,100,000
Deferred underwriting commissions per unit	$ 0.35
Deferred underwriting commissions	$ 10,675,000		$ 10,675,000
Over-allotment option
COMMITMENTS AND CONTINGENCIES
Period of over-allotment	45 days	45 days
Maximum number of units to be issued	4,000,000	4,500,000
Number of units sold	500,000
Option to purchase number of units expired				4,000,000

COMMITMENTS AND CONTINGENCIES_3

COMMITMENTS AND CONTINGENCIES - Deferred Legal Fees (Details)	Sep. 30, 2023 USD ($)
COMMITMENTS AND CONTINGENCIES
Deferred legal fees	$ 319,237

SHAREHOLDER'S EQUITY - Preferre

SHAREHOLDER'S EQUITY - Preferred Shares (Details)	Sep. 30, 2023 $ / shares shares
SHAREHOLDER'S EQUITY
Preference shares, shares authorized	5,000,000
Preference shares, par value \| $ / shares	$ 0.0001
Preference shares, shares issued	0
Preference shares, shares outstanding	0

SHAREHOLDER'S EQUITY - Ordinary

SHAREHOLDER'S EQUITY - Ordinary Shares (Details)					6 Months Ended
SHAREHOLDER'S EQUITY - Ordinary Shares (Details)	Aug. 27, 2023 shares	Jul. 18, 2023 shares	Jul. 13, 2023 shares	Apr. 12, 2023	Sep. 30, 2023 Vote $ / shares shares	Jun. 16, 2023 $ / shares shares	Apr. 24, 2023 shares
Over-allotment option
SHAREHOLDERS' EQUITY
Option to purchase number of units expired	4,000,000
Number of units sold		500,000
Number of shares subject to forfeiture		500,000
Period of over-allotment		45 days		45 days
Sponsor and the independent directors
SHAREHOLDERS' EQUITY
Number of units sold		500,000
Class A ordinary shares
SHAREHOLDERS' EQUITY
Ordinary shares, shares authorized					500,000,000
Ordinary shares, par value \| $ / shares					$ 0.0001
Ordinary shares subject to possible redemption, shares					30,500,000
Ordinary shares, shares issued					0
Ordinary shares, shares outstanding.					0
Number of votes per share \| Vote					1
Conversion ratio					1
Class B ordinary shares
SHAREHOLDERS' EQUITY
Ordinary shares, shares authorized					50,000,000
Ordinary shares, par value \| $ / shares					$ 0.0001
Ordinary shares, shares issued					0
Ordinary shares, shares outstanding.					0
Number of votes per share \| Vote					10
Conversion ratio					1
Class F ordinary shares
SHAREHOLDERS' EQUITY
Ordinary shares, shares authorized					50,000,000
Ordinary shares, par value \| $ / shares					$ 0.0001
Number of shares issued			50,000
Number of shares held.	7,625,000
Number of shares forfeited	1,000,000
Number of shares subject to forfeiture			100,000
Ordinary shares, shares issued					7,625,000
Ordinary shares, shares outstanding.					7,625,000
Number of votes per share \| Vote					1
Conversion ratio					1
Class F ordinary shares \| Sponsor
SHAREHOLDERS' EQUITY
Number of shares issued			100,000
Number of shares held.			8,525,000			8,625,000
Issue price per share \| $ / shares						$ 0.003
Number of shares forfeited			100,000
Percentage of issued and outstanding shares					20%
Ordinary shares, shares issued						2,875,000	5,750,000
Class F ordinary shares \| Sponsor and the independent directors
SHAREHOLDERS' EQUITY
Number of shares held.	7,625,000
Number of shares subject to forfeiture	1,000,000

SHAREHOLDER'S EQUITY - Warrants

SHAREHOLDER'S EQUITY - Warrants (Details)	6 Months Ended
SHAREHOLDER'S EQUITY - Warrants (Details)	Sep. 30, 2023 $ / shares shares
Warrant Instruments
Number of warrants outstanding \| shares	24,790,000
Exercise price of warrant	$ 11.50
Expiration term (in years)	5 years
Warrants exercisable term after the completion of an initial Business Combination	30 days
Threshold period for filling registration statement after business combination	20 days
Threshold period for registration statement to be effective after which warrants can be expired or redeemed	60 days
Redemption of warrants for cash when the price per Class A ordinary share equals or exceeds $18.00
Warrant Instruments
Redemption price per warrant (in dollars per share)	$ 0.01
Minimum threshold written notice period for redemption of warrants	30 days
Threshold trading days for redemption of warrants	20 days
Threshold period for completion of Business Combination	150 days
Class A ordinary shares
Warrant Instruments
Percentage of gross proceeds on total equity proceeds	60%
Threshold trading days for calculating market value	10 days
Adjustment of exercise price of warrants based on market value and newly issued price (as a percent)	115%
Stock price trigger for redemption of public warrants (in dollars per share)	$ 18
Adjustment of redemption price of stock based on market value and newly issued price (as a percent)	180%
Threshold period for not to transfer, assign or sell any of their shares or warrants after the completion of the initial business combination	30 days
Redemption period of warrants	30 days
Class A ordinary shares \| Minimum
Warrant Instruments
Threshold issue price for capital raising purposes in connection with the closing of a Business Combination	$ 9.20

FAIR VALUE MEASUREMENTS (Detail

FAIR VALUE MEASUREMENTS (Details) - USD ($)	Sep. 30, 2023	Aug. 27, 2023	Jul. 18, 2023
Assets:
Marketable securities held in Trust Account	$ 311,408,512
Over-allotment option
Liabilities:
Option to purchase number of units expired		4,000,000
Cash
Assets:
Marketable securities held in Trust Account	853
U.S. Treasury securities
Assets:
Marketable securities held in Trust Account	311,407,659
Level 1 \| Recurring
Assets:
Marketable securities held in Trust Account	$ 311,407,659
Level 3 \| Over-allotment option
Liabilities:
Liabilities			$ 402,224

FAIR VALUE MEASUREMENTS - Over-

FAIR VALUE MEASUREMENTS - Over-allotment option (Details) - Over-allotment option	Jul. 18, 2023 Y USD ($)
Risk-free interest rate
FAIR VALUE MEASUREMENTS
Measurement input	0.0537
Expected term (years)
FAIR VALUE MEASUREMENTS
Measurement input \| Y	0.12
Expected volatility
FAIR VALUE MEASUREMENTS
Measurement input	0.0449
Exercise price
FAIR VALUE MEASUREMENTS
Measurement input	10
Fair value of over-allotment unit
FAIR VALUE MEASUREMENTS
Measurement input	0.101

FAIR VALUE MEASUREMENTS - Chang

FAIR VALUE MEASUREMENTS - Changes in the fair value of the Level 3 financial instruments (Details) - Level 3 - Recurring - Over-allotment option - USD ($)	2 Months Ended	3 Months Ended
	Sep. 30, 2023	Jul. 18, 2023
Changes in the fair value
Fair value at beginning of the year	$ 402,224
Initial measurement of over-allotment option at July 18, 2023		$ 402,224
Derecognition of over-allotment option liability on August 27, 2023	$ (402,224)
Fair value at the end of the year		$ 402,224

FAIR VALUE MEASUREMENTS - Publi

FAIR VALUE MEASUREMENTS - Public warrants (Details) - Public Warrants	Jul. 18, 2023 USD ($) Y
Market price of public stock
FAIR VALUE MEASUREMENTS
Measurement input \| $	10.12
Term (years)
FAIR VALUE MEASUREMENTS
Measurement input \| Y	5
Risk-free rate
FAIR VALUE MEASUREMENTS
Measurement input	0.0391
Dividend yield
FAIR VALUE MEASUREMENTS
Measurement input	0
Volatility
FAIR VALUE MEASUREMENTS
Measurement input	0.400
Probability of merger
FAIR VALUE MEASUREMENTS
Measurement input	8

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($)	3 Months Ended		6 Months Ended
Pay vs Performance Disclosure - USD ($)	Sep. 30, 2023	Jun. 30, 2023	Sep. 30, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ 3,507,082	$ (7,427)	$ 3,499,655

Insider Trading Arrangements

Insider Trading Arrangements	6 Months Ended
Insider Trading Arrangements	Sep. 30, 2023
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false